Amazing Few Weeks: Winter Surprise for RVXIt has been an amazing few weeks for Resverlogix. Once news of attaining Phase 3 came in January, I had expected a gradual increase in the stock price - but nowhere near what we experienced. There has been a lot of sustained buying. Fantastic.
I think we have some continued positive times ahead - at least through "first dosing" under the new reMace trial. That should occur in late June or perhaps soon thereafter. I think an increasing number of people will be wanting to own the stock going into that trial - and fewer and fewer people will be selling. Hence, I think we will see continued strength in the stock price - and some new 52 week highs. Just my personal opinion. I obviously don't have a crystal ball!
I think there are a number of potential positive events on the horizon that will help us along in this path:
1. News of details of the planned reMACE trial (any time now)
2. News of IND filing (should be next month I think)
3. News of first dosing (end of June, I'm guessing based upon company communications)
4. Potential news about how soon we might get data out of this upcoming reMACE trial. This is related to #1 on the list above. There are rumours that the company might have data well before the 2 year estimated end of the trial. Could be a lot sooner than that, or so some have said on this board.
5. News of the (potential) other two Phase 3 trials. One of them is for PAD. The other for an unknown condition. Both could drive the stock price higher.
6. There's always the potential for a buyout offer or a partnership offer coming to fruition - for either RVX or Zenith or both.
7. There are rumours of a potential listing on NASDAQ in the USA.
8. Etc.
I think that RVX.TO will head past $2 (CAD) in the near future. Possibly much higher than that.
I think the last time things looked this good was in the months leading up to ASSURE results being announced. That time things ended badly. This time we might have a very different story to tell.
DYODD. GLTA. IMHO.